You have no items in your shopping cart.
Human CD3D&CD3E Heterodimer [orb2993825]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&39.2 KDa. Observed: 40-60 KDa, reducing conditions
50 μg, 1 mg, 10 μg, 500 μg- Biotinylated Human CD3E [orb2993856]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.5 KDa. Observed: 45-60 KDa, reducing conditions
20 μg, 100 μg - Recombinant Human CD3D&CD3E Heterodimer (C-6His) [orb2993864]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.6&12.8 KDa. Observed: 16-30 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human CD3E [orb2994304]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 40-50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus CD3d [orb2994176]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.4 KDa. Observed: 20-35 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Cynomolgus CD3E [orb2994067]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3E [orb2993920]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 32-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus CD3D&CD3E Heterodimer [orb2993714]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&38.3 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3E&CD3G Heterodimer [orb2993735]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.2&38.1 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Cynomolgus CD3d [orb2994733]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 50-65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg